Sleep Apnea Detection: Lessons From A Care Program At Onsite Health Clinics

by Brian Lemay, MS-HCA, Hani Kayyali, Kirk Scovill, Sarah Weimer, Eugene Estok, and Ted Bellezza, as seen in Nurse Practitioner Perspective Nov/Dec 2014, pages 34 – 37
ALTHOUGH thousands of corporations have implemented programs and incentives to improve employee health, many continue to overlook an issue that negatively affects operational efficiency and may result in unnecessarily high healthcare costs. Research shows that employees with obstructive sleep apnea (OSA) have persistently lower productivity and higher absenteeism and consume more total healthcare dollars.
Read Publication >

PRIMARY CARE AND SLEEP APNEA TESTING: A PILOT STUDY FOR HOME TESTING

by Thomas D. Schwieterman MD, Hani Kayyali, Kirk Scovill
Patients with OSA are at significantly higher risk for developing hypertension, diabetes, heart disease, obesity and sudden death. Despite a high prevalence for OSA in all primary care practice populations, too few patients are screened for the disorder and fewer are tested. The gold standard and most common modality for achieving a diagnosis for OSA has traditionally been the in-lab polysomnogram (PSG). Yet, home sleep testing equipment and methodologies have been shown to be of comparable efficacy, are lower cost and can be effectively administered by primary care physicians.
Read White Paper >

HOME SLEEP TESTING CAN IMPROVE PATIENT CARE

by Sarah Weimer (PDF as seen in Sleep Diagnosis and Therapy Magazine)
The changing reimbursement and acceptance of home sleep testing by insurance payers and sleep professionals will open up opportunities for improved patient care and will provide sleep labs with a means to expand the reach of their sleep services. Many patient populations are well suited for home sleep diagnostic testing…
Read Publication >

SELF-ADMINISTERED WIRELESS MONITOR FOR COMPREHENSIVE EVALUATION OF CPAP BENEFIT IN THE HOME

by Hani Kayyali (as seen in Sleep Diagnosis and Therapy)
…Effective treatment exists; however, once prescribed therapeutic benefit is not monitored adequately. Many patients, especially those with comorbidities, may require pressure adjustments, supplemental therapy, or different intervention that maybe difficult to identify with current therapy assessment techniques….
Read Publication >